Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted FDA opportunity for applied regulatory science research to evaluate and treat the cardiotoxicity of oncology therapeutics. No eligibility details, funding amounts, or deadline …
- Deadline
- Not specified
- Posted
- Nov 20, 2024
- Award amount
- Amount not specified
In plain English
This is a forecasted FDA opportunity for applied regulatory science research to evaluate and treat the cardiotoxicity of oncology therapeutics. No eligibility details, funding amounts, or deadline have been published yet, so it is not currently open for applications. Watch for the full notice before preparing a proposal.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from Food and Drug Administration — soonest deadline first.
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration · Up to $250K · Due Jan 29, 2027
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration · Up to $600K · Due Feb 8, 2028
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration · Up to $1.3M · Due May 12, 2028
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration · Up to $900K · Due May 16, 2028
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Food and Drug Administration · Amount varies · No deadline listed
Also listed under Food and Drug Administration.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.